Home  >  News
Eppen_CellXpert_Mar2026
you can get e-magazine links on WhatsApp. Click here
News
  Merck to present new data from cardio-pulmonary pipeline at the ACC.26 in New Orleans, from March 28-30,   March 17, 2026
  Allergan Aesthetics redefines skin quality communication with launch of Skin Quality Index,   March 17, 2026
  ASPA–CRISIL “State of Counterfeiting in India 2025” report reveals counterfeit medicines account for around 28% of the market,   March 17, 2026
  Bayer announces finerenone meets primary endpoint in pivotal phase III FIND-CKD study in patients with non-diabetic chronic kidney disease,   March 17, 2026
  IIT Roorkee inaugurates Ashok Soota Molecular Medicine Facility at BSBE to advance translational biomedical research,   March 17, 2026
  Pulse of Positivity Health and Wellness Summit 2026 brings policymakers, doctors, to shape the future of health in India,   March 17, 2026
  Lupin and Zydus ink licensing agreement to co-market innovative semaglutide injection in India,   March 17, 2026
  Himachal Institute of Pharmacy hosts 2-day Intl Conference on Pharmacy Beyond Borders: Translating Innovation for Global Health,   March 17, 2026
  GN Store Nord enters into agreement to sell its hearing business to Amplifon for DKK 17.0 billion,   March 17, 2026
  Lundbeck to present phase 1b data on Lu AF28996, an investigational treatment for people with advanced Parkinson’s disease at the 2026 AD/PD conference,   March 17, 2026
  ZEISS India and Ashoka University Launch Professional Course in Advanced Microscopy (PCAM) 2026,   March 17, 2026
  First World Health Congress sees India to become a hub for global health collaboration,   March 17, 2026
  AstraZeneca’s Imfinzi in combo with standard-of-care FLOT chemotherapy gets European approval to treat patients with early gastric and gastroesophageal cancers,   March 17, 2026
  Samsung Bioepis and Epis NexLab ink research collaboration and license pact with G2GBIO to develop novel assets including long-acting semaglutide,   March 17, 2026
  US FDA accepts Sun Pharma’s sBLA for Ilumya to treat adults with active psoriatic arthritis,   March 17, 2026
  Eli Lilly’s phase 3 ADorable-1 trial of Ebglyss in paediatric patients with moderate-to-severe atopic dermatitis meets primary and key secondary endpoints,   March 17, 2026
  India’s Rs. 1,000 crore MedTech Fund signals strategic shift toward domestic manufacturing,   March 17, 2026
  Study affirms superiority of iMDx GraftAssure assay’s proprietary dd-cfDNA combination model score,   March 16, 2026
  US FDA clears Unixell Biotech’s IND for allogeneic iPSC-derived cell therapy, UX-GIP001 for focal epilepsy,   March 16, 2026
  Maharashtra govt forms Committee to give autonomy to two govt hospitals in Mumbai and Nagpur,   March 16, 2026

 Back
 
Propak_Asia_2026
CP_CPHI_Korea2026
IWE_CP_2026
ChemExpo_India_2026
PharmaTech_expo_Chandigarh2026
ASIA_PHARMA_EXPO_2026
CPHI_Japan26
Ana_Lab_India_2026
PharmaCore_India_2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram